Phenol or laser: which works better for pilonidal sinus?

NCT ID NCT06721169

Recruiting now Disease control Sponsor: Mersin University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times

Summary

This study compares two minimally invasive treatments for pilonidal sinus disease: phenol injection and laser ablation. Researchers will track complications, hospital stay, and recovery time in 64 adults with uncomplicated pilonidal sinus. The goal is to find which method is safer and gets people back to daily life faster.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: phenol (sclerosing agent) and laser ablation (thermal energy)
What this could lead to: If successful, this could show which minimally invasive treatment is more effective for pilonidal sinus disease, helping patients recover faster with fewer complications.
What could go wrong: This is a small, early-stage observational study with only 64 participants, so results may not apply to everyone. Both treatments have risks like infection or incomplete healing.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PILONIDAL SINUS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pilonidal sinus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PILONIDAL SINUS DISORDER PILONIDAL SINUS TREATMENT SURGICAL OUTCOMES

Contacts and locations

Locations

Mersin University
RECRUITING

Mersin, 33010, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.